Back to search

Article

Pembrolizumab induced hyperpigmentation in a patient with lung adenocarcinoma: a case report

2021-07-05

Abstract excerpt

Pembrolizumab is more widespread use clinically with Pembrolizumab being recommended as a first-line therapy for advanced NSCLC. At the same time, some new adverse reactions have also been discovered, including hyperpigmentation. We hereby present a 77-year-old Chinese female with primary bronchial lung cancer. Genetic testing showed negative for EGFR and ALK. Immunohistochemical analysis showed tumor proportion s...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
78a2f0ef-46b9-54b3-b75f-00d0ab8c349f
DOI
10.22541/au.162546820.05792179/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pembrolizumab induced hyperpigmentation in a patient with lung adenocarcinoma: a case reportDOI 10.22541/au.162546820.05792179/v1
Select a neighboring publication to make it the new centre.